# Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns

> **NCT00955487** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 124 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Inhaled Nitric Oxide (iNO)
- **DRUG:** Nitrogen (placebo)

## Key facts

- **NCT ID:** NCT00955487
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2017-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955487, "Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00955487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*